highly significantP < 0.0001
In 12,899 patients, the improvement in the ROC curve area of APACHE III compared with APACHE II was highly significant (P < 0.0001).
In 12,899 patients, the improvement in the ROC curve area of APACHE III compared with APACHE II was highly significant (P < 0.0001).